Arterra Bioscience SpA (ARBS) Stock Statistics & Valuation Metrics

Arterra Bioscience SpA has a market cap or net worth of EUR 20.44M. The enterprise value is EUR 17.42T.

Market Cap

EUR 20.44M

Enterprise Value

EUR 17.42T

Arterra Bioscience SpA has 6,658,493 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

6,658,493

Owned by Insiders

20.89%

Owned by Institutions

―

Arterra Bioscience SpA’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 4.29%.

Return on Equity (ROE)

0.16

Return on Assets (ROA)

0.14

Return on Invested Capital (ROIC)

4.29%

Return on Capital Employed (ROCE)

0.04

Revenue Per Employee

122.35K

Profits Per Employee

52.80K

Employee Count

38

Asset Turnover

0.32

Inventory Turnover

2.54

The current PE Ratio of Arterra Bioscience SpA is 12.08. Arterra Bioscience SpA’s PEG ratio is -1.13.

PE Ratio

12.08

PS Ratio

3.85

PB Ratio

1.63

Price to FCF

15.47

Price to Operating Cash Flow

12.06

PEG Ratio

-1.13

In the last 12 months, Arterra Bioscience SpA had revenue of 4.65M and earned 2.01M in profits. Earnings per share was 0.30.

Revenue

4.65M

Gross Profit

737.89K

Operating Income

591.76K

Pretax Income

2.00M

Net Income

2.01M

EBITDA

881.95K

Earnings Per Share (EPS)

0.30

In the last 12 months, operating cash flow was 1.67M and capital expenditures -396,308, giving a free cash flow of 1.27M billion.

Operating Cash Flow

1.67M

Free Cash Flow

1.27M

Free Cash Flow per Share

0.19

Arterra Bioscience SpA pays an annual dividend of EUR 0.13, resulting in a dividend yield of 4.97%

Dividend Per Share

EUR 0.13

Dividend Yield

4.97%

Payout Ratio

N/A

Free Cash Flow Yield

6.46%

Earnings Yield

8.27%

Beta

0.42

52-Week Price Change

-3.21%

50-Day Moving Average

3.04

200-Day Moving Average

2.95

Relative Strength Index (RSI)

49.63

Average Volume (3m)

4,430

Arterra Bioscience SpA upcoming earnings date is ―, TBA (Not Confirmed).

Last Earnings Date

―

Next Earnings Date

―

Ex-Dividend Date

May 05, 2025

Arterra Bioscience SpA as a current ratio of 7.74, with Debt / Equity ratio of 2.07%

Current Ratio

7.74

Quick Ratio

5.99

Debt to Market Cap

0.01

Net Debt to EBITDA

-1.23

Interest Coverage Ratio

667.15

In the past 12 months, Arterra Bioscience SpA has paid -8,495 in taxes.

Income Tax

-8,495

Effective Tax Rate

-0.00

Arterra Bioscience SpA EV to EBITDA ratio is 22.05, with an EV/FCF ratio of 14.63.

EV to Sales

3.64

EV to EBITDA

22.05

EV to Free Cash Flow

14.63

EV to Operating Cash Flow

11.15

Arterra Bioscience SpA has EUR 1.31M in cash and marketable securities with EUR 238.41K in debt, giving a net cash position of EUR 1.07M billion.

Cash & Marketable Securities

EUR 1.31M

Total Debt

EUR 238.41K

Net Cash

EUR 1.07M

Net Cash Per Share

EUR 0.16

Tangible Book Value Per Share

EUR 1.85

Gross margin is 14.40%, with operating margin of 10.39%, and net profit margin of 32.58%.

Gross Margin

14.40%

Operating Margin

10.39%

Pretax Margin

38.67%

Net Profit Margin

32.58%

EBITDA Margin

16.52%

EBIT Margin

10.39%

The average price target for Arterra Bioscience SpA is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

0

Revenue Growth Forecast

13.59%

EPS Growth Forecast

-12.69%